GL1X · GenesisL1 explorer

MolNFT v1 · #109442 · protein

X-ray crystal structure of the orally available aminopeptidase inhibitor, tosedostat, bound to the M1 alanyl aminopeptidase from P. falciparum

4X2U · M1 family aminopeptidase: “X-ray crystal structure of the orally available aminopeptidase inhibitor, tosedostat, bound to the M1 alanyl…”. X-ray diffraction, 3 ligands (TOD, MG, ZN), 11 pockets (best druggability 0.79). MolNFT v1…

PDB
4X2U
Type
protein
Length
889 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
M1 family aminopeptidase
EC
3.4.11.-
UniProt
O96935
Ligands
TOD, MG, ZN
Pockets
11 · best druggability 0.79

Structure

x-ray diffraction · 1 distinct chain · 45% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AM1 family aminopeptidase (EC 3.4.11.-)protein88945% helix, 21% strandO96935

Ligands and binding sites

  • TOD · (2S)-({(2R)-2-[(1S)-1-hydroxy-2-(hydroxyamino)-2-oxoethyl]-4-methylpentanoyl}amino)(phenyl)ethanoic acid · ligand · chains A
  • MG · Magnesium ion · metal · 4 copies · chains A
  • ZN · Zinc ion · metal · chains A
  • GOL · Glycerol · additive · 8 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

11 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14450.790.8769TOD, GOL
23620.770.8751GOL
36630.690.7765empty
42140.690.8637empty
53300.580.7646GOL, MG

Compared structures

  • 4X2U · X-ray crystal structure of the orally available aminopeptidase inhibitor, Tosedostat… · the same entry in another collection · chain A against A, TM-score 1.00
  • O96935 · AlphaFold monomer V2.0 prediction for M1 family aminopeptidase (O96935) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.